Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 23, 2024Clinical Microbiology and InfectionOpen Access

Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease

View Full Paper
Ask AI
Bookmark
Share

Authors

MTMarta Pozuelo TorresJIJakko van Ingen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Torres et al. (2024) studied this question.

synapsesocial.com/papers/68e72a70b6db6435876a4529https://doi.org/10.1016/j.cmi.2024.03.019
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Eradicating Pulmonary Mycobacterium abscessus : The Promise of Dual β-Lactam Therapy2023 · 22 citations
  2. 2Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline2020 · 935 citations
  3. 3Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis1995 · 165 citations
  4. 4Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus2015 · 44 citations
  5. 5First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus2020 · 35 citations